CAMARDA, Valeria
 Distribuzione geografica
Continente #
NA - Nord America 2.964
EU - Europa 592
AS - Asia 390
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
AF - Africa 1
OC - Oceania 1
Totale 3.952
Nazione #
US - Stati Uniti d'America 2.950
CN - Cina 240
UA - Ucraina 167
DE - Germania 135
TR - Turchia 116
GB - Regno Unito 104
IT - Italia 70
SE - Svezia 46
FI - Finlandia 43
VN - Vietnam 27
CA - Canada 14
BE - Belgio 9
FR - Francia 7
RU - Federazione Russa 4
IN - India 3
A2 - ???statistics.table.value.countryCode.A2??? 2
IR - Iran 2
NL - Olanda 2
PL - Polonia 2
AR - Argentina 1
AT - Austria 1
AU - Australia 1
EC - Ecuador 1
HK - Hong Kong 1
IE - Irlanda 1
LU - Lussemburgo 1
NP - Nepal 1
ZA - Sudafrica 1
Totale 3.952
Città #
Fairfield 475
Woodbridge 431
Houston 245
Jacksonville 188
Ashburn 186
Seattle 175
Chandler 173
Cambridge 161
Ann Arbor 139
Wilmington 136
Nanjing 63
Izmir 62
Beijing 51
San Diego 47
New York 44
Princeton 40
Milan 35
Boardman 29
Dong Ket 26
Shanghai 26
Munich 23
Dearborn 22
Bremen 20
Addison 16
Hebei 16
Mcallen 16
Shenyang 16
Nanchang 13
Auburn Hills 12
Montréal 12
Changsha 10
Brussels 9
Ferrara 9
Norwalk 9
Philadelphia 9
Helsinki 8
Jiaxing 7
Jinan 7
Tianjin 7
Mountain View 6
Ningbo 6
Falls Church 5
Indiana 5
London 5
Tappahannock 5
Los Angeles 4
Redwood City 4
San Mateo 4
Kunming 3
Orange 3
Redmond 3
Verona 3
Zhengzhou 3
Acton 2
Augusta 2
Aurora 2
Bologna 2
Des Moines 2
Guangzhou 2
Hefei 2
Hounslow 2
Lanzhou 2
Lodz 2
Monmouth Junction 2
Padova 2
Prescot 2
San Francisco 2
Taizhou 2
Toronto 2
Wandsworth 2
Washington 2
Ardabil 1
Boston 1
Buffalo 1
Chicago 1
Chiswick 1
Collecorvino 1
Dublin 1
Düsseldorf 1
Fuzhou 1
Hanoi 1
Hendon 1
Islington 1
Kilburn 1
La Canada Flintridge 1
Las Vegas 1
Leawood 1
Leicester 1
Liberty Lake 1
Loja 1
Luxembourg 1
Mansfield 1
Nole 1
Phoenix 1
Pune 1
Río Cuarto 1
Sabz 1
San Jose 1
Santa Clara 1
Sanwal 1
Totale 3.097
Nome #
Chimeric G proteins in fluorimetric calcium assays: Experience with opioid receptors 227
null 205
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. 142
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 128
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 127
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 125
A new ligand for the urotensin II receptor 124
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 120
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 114
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 113
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. 111
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists. 110
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor. 107
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 105
Structure-activity study at positions 3 and 4 of human neuropeptide S. 105
Inhibitory effects of putative peptidic urotensin-II receptor antagonists on urotensin-II-induced contraction of cat isolated respiratory smooth muscle 104
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 103
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 102
Pharmacological characterisation of novel kinin B2 receptor ligands 102
The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems 102
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 102
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 100
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 100
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 98
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists. 95
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68). 94
Structure-activity relationship study on human urotensin II 94
null 94
Differential agonistic and antagonistic effects of the urotensin-II ligand SB-710411 at rodent and primate UT receptors 92
Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol. 88
null 87
Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Galpha(qi5). 82
null 78
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen(5), DTrp(7), Dab(8)] urotensin II(4-11) (UFP-803) 77
Synthesis and Structure-Activity Relationships of (-)-cis-N-Normetazocine-Based LP1 Derivatives 63
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]NPS. 60
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 52
Pharmacological profile and antiparkinsonian properties of the novel nociceptin/orphanin FQ receptor antagonist 1-[1-Cyclooctylmethyl-5-(1-hydroxy-1-methyl-ethyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-3-ethyl-1,3-dihydro-benzoimidazol-2-one (GF-4). 22
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. 19
Synthesis and Structure–Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands 14
Totale 3.987
Categoria #
all - tutte 13.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 470
Totale 14.077


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019402 0 0 0 0 0 0 0 0 0 0 166 236
2019/20201.024 137 39 33 152 84 123 98 104 86 94 51 23
2020/2021580 48 62 26 91 23 50 31 62 13 59 61 54
2021/2022456 17 52 54 5 31 14 31 26 13 41 41 131
2022/2023439 43 26 15 51 79 59 34 35 56 1 21 19
2023/2024182 21 32 15 8 8 59 11 21 3 4 0 0
Totale 3.987